Tissue transglutaminase and the progression of human renal scarring

Timothy S. Johnson, Ahmed F. El-Koraie, N. James Skill, Nahed M. Baddour, A. Meguid El Nahas, Melvin Njloma, Ahmed G. Adam, Martin Griffin

Research output: Contribution to journalArticle

88 Scopus citations


Experimental renal scarring indicates that tissue transglutaminase (tTg) may be associated with the accumulation of extracellular matrix (ECM), both indirectly via TGF-β1 activation and directly by the formation of ε(γ-glutamyl) lysine dipeptide bonds within the ECM. The latter potentially accelerates deposition and confers the ECM with resistance to proteolytic digestion. Studied were 136 human renal biopsy samples from a range of chronic renal diseases (CRD) to determine changes in tTg and ε(γ-glutamyl) lysine crosslinking. Immunofluorescence for insoluble tTg showed a 14-fold increase in the kidneys of CRD patients (5.3 ± 0.5 versus 76 ± 54 mV/cm2), which was shown to be active by a similar 11-fold increase in the ε(γ-glutamyl) lysine crosslink (1.8 ± 0.2 versus 19.3 ± 14.2 mV/cm2). Correlations were obtained with renal function for tTg and crosslink. In situ hybridization for tTg mRNA showed that tubular epithelial cells were the major source of tTg; however, both mesangial and interstitial cells also contributed to elevated levels in CRD. This mRNA pattern was consistent with immunohistochemistry for soluble tTg. Changes in renal tTg and its product, the ε(γ-glutamyl) lysine crosslink, occur in progressive renal scarring in humans independently of the original etiology and in a similar manner to experimental models. tTg may therefore play a role in the pathogenesis of renal scarring and fibrosis in patients with CRD and can therefore be considered a potential therapeutic target.

Original languageEnglish (US)
Pages (from-to)2052-2062
Number of pages11
JournalJournal of the American Society of Nephrology
Issue number8
StatePublished - Aug 1 2003

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Tissue transglutaminase and the progression of human renal scarring'. Together they form a unique fingerprint.

  • Cite this

    Johnson, T. S., El-Koraie, A. F., Skill, N. J., Baddour, N. M., El Nahas, A. M., Njloma, M., Adam, A. G., & Griffin, M. (2003). Tissue transglutaminase and the progression of human renal scarring. Journal of the American Society of Nephrology, 14(8), 2052-2062. https://doi.org/10.1097/01.ASN.0000079614.63463.DD